Epirubicin-carboplatin-capecitabine (ECarboX) in relapsed ovarian cancer: A phase I/II trial

R. Hübner,Tanya Ahmad,A. Rigg,Stan B. Kaye,I Gibbens,C. Keyzor,A. Prouse,M. Gore

Epirubicin-carboplatin-capecitabine (ECarboX) in relapsed ovarian cancer: A phase I/II trial

2004

R. Hübner
Tanya Ahmad
A. Rigg
Stan B. Kaye
I Gibbens
C. Keyzor
A. Prouse
M. Gore

5109 Background: We have previously shown the combination of epirubicin, cisplatin, and prolonged infusional 5-fluorouracil (5-FU) is active in relapsed epithelial ovarian cancer (EOC). Capecitabin...

Keywords:

Ovarian cancer
Physical therapy
Capecitabine
Carboplatin
Cancer research
Oncology
Epirubicin
Internal medicine
Medicine
Capecitabin
epithelial ovarian cancer
Cisplatin
phase i ii

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations